Contact Us marketing@medicilon.com
Medicilon Logo
|
search icon search icon 中 contact icon menu icon
Medicilon Logo
|
search icon close search icon 中 contact icon menu icon
ABOUT
Company Profile
Corporate Culture
Management Team
Company History
Message from the CEO
Honors and Awards
Over 20 years of experience in R&D
Learn more
01 Drug Discovery
Chemistry Research
Biology Research
Early Pharmacokinetics
02 Pharmaceutical Research
Intermediates
Active Pharmaceutical Ingredients
Pharmaceutical preparation
Analytical Method Development and Quality Control
CMC Filings
Analytical Testing Center
03 Preclinical Research
Pharmacology & Pharmacodynamics
Drug Safety Evaluation
DMPK
Bioanalysis
IND Filings
01 One-stop Integrated Services
Liposome Drug Development
Drug Discovery
Pharmaceutical Research
Preclinical Research
Botanical Drug Preclinical R&D
02 Innovative Drug Services
ADC
PROTAC
mRNA Vaccine
Cellular Immunotherapies
Nucleic Acid Drug
Peptide Drug Conjugate (PDC)
Antibody
03 Key Technical Services for Drug R&D
Cytokine and Biomarker Detection
Metabolite Identification (MetID)
Drug Forming Research
Flow Cytometry Technology
SEND Format Conversion
Flow Sorting
NanoString nCounter Detection
Routes of Drug Administration
04 Drug Efficacy Evaluation for Common Diseases
IO Pharmacodynamic Model
Inflammatory and Immune Diseases
Rodent Cerebrovascular Disease
05 Advanced Preparation R&D
Inhalation drug
Ophthalmic drug
Skin Topical Preparation
06 Targeted Drugs R&D Services
STAT3-targeted Drugs R&D Service
GLP-1 New Drug R&D Service
KRAS-targeted Drugs R&D Service
CAREERS
Talent Development
Campus Recruitment
Recruitment
Campus Recruitment
Campus Recruitment
Recruitment
Recruitment
News
Medicilon Events
Featured Stories
Market Events
Videos
A.C.E.
2024-07-22Medicilon Events
The Shanghai Overseas Returned Scholars Association invites the Dutch PhD delegation to visit Medicilon, exploring paths for innovative development together
On July 4th, the Shanghai Overseas Returned Scholars Association invited the Dutch PhD delegation to visit the Chuansha campus of Shanghai Medicilon Inc. (Medicilon) and held discussions with Medicilon's Founder and CEO, Chunlin Chen, among others.
Learn more
2024-07-22Medicilon Events
5th consecutive win! Medicilon once again made the list of "Top 20 Chinese R&D CRO Enterprises in 2024"
Medicilon stood out among hundreds of pharmaceutical enterprises and was honored with the "Top 20 Chinese R&D CRO Enterprises in 2024" award.
Learn more
INVESTORS
Stock Information
Investment Contact
Medicilon 688202
RMB

As of Beijing time The data is from a third-party organization and is only for reference.

For actual information, please refer to：www.eastmoney.com

CLIENT CENTER
Intellectual Property Protection
Clients Testimonials
Downloads
Partnerships
Medicilon Support
Newsletters
U.S.

Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)

Tel: +1(626)986-9880

UK

Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK

Tel: 0044 7790 816 954

Email: marketing@medicilon.com

China

Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)

Postcode: 201299

Tel: +86 (21) 5859-1500 (main line)

Fax: +86 (21) 5859-6369

Close

© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3

Shanghai Public Network Security File No. 31011502018888 | Website Map

© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3
Shanghai Public Network Security File No. 31011502018888|Website Map
关闭
中
Message
Contact Us
Close Button
Back To Top
Online Message×
Click switch
Close Button
News and Events
Medicilon Events Featured Stories Market Events Videos A.C.E.
HomenewsFeatured Stories

Featured Stories

Hot information：
Top 10 Global CDMO Enterprises| The Meaning of IND, NDA and ANDA| Top 10 Global Clinical Research Organizations in 2021
Nov 30,2018
Cancer Drug Discovery Gets Boost from Novel Proteomics Platform
Scientists at the Van Andel Research Institute have developed a novel biochemical platform to research a family of enzymes that are promising targets for cancer treatment. The study ("A functional proteomics platform to reveal the sequence determinants of lysine methyltransferase substrate selectivity”), published in Science Advances, describes a new method that provides a high-resolution view of howRead more
More
Cancer Drug Discovery Gets Boost from Novel Proteomics Platform
Nov 29,2018
Staph Genes That Turn Commensal to Killer Identified
Don't be alarmed, but a bacterium that could turn deadly is on your skin right now. This bacterium, Staphylococcus epidermis, is usually harmless, but it may harbor genes that could help it exploit any opportunity to grow in your bloodstream. Once there, it could shrug off your immune response, resist the antibiotics you receive, andRead more
More
Nov 29,2018
Method Predicts Exact Mutations CRISPR Gene Editing Can Introduce into a Cell
The largest study of CRISPR action to date has developed a method to predict the exact mutations CRISPR-Cas9 gene editing can introduce to a cell. Researchers at the Wellcome Sanger Institute edited 40,000 different pieces of DNA and analysed a thousand million resulting DNA sequences to reveal the effects of the gene editing and developRead more
More
Method Predicts Exact Mutations CRISPR Gene Editing Can Introduce into a Cell
Nov 28,2018
Two-Pronged Approach Shows Promise against Drug-Resistant Cancers
Researchers at the University of California, San Francisco (UCSF) report that they have discovered why some lung cancers become drug-resistant after initially responding to targeted therapies. In the process, they say they devised a new two-pronged approach that yields an effective treatment for these cancers in the laboratory and holds promise for the future ofRead more
More
Two-Pronged Approach Shows Promise against Drug-Resistant Cancers
Nov 28,2018
Brown Fat-Boosting Protein Points to Safer Anti-Obesity Strategies
An international team of scientists has identified a protein that boosts the energy-burning activity of brown fat in mice, and which could feasibly lead to the development of new therapeutic approaches for treating obesity in humans. The research, headed by a team at the University of Cambridge, U.K., showed that the protein, BMP8b, effectively superchargesRead more
More
Nov 27,2018
Universal DNA Database Could Keep Police Investigations in Bounds
Imagine a DNA database populated with data from every individual in society and made available to law enforcement. Such a database sounds ominous, especially if you've watched Black Mirror or similarly dystopian-themed programs. But such a DNA database could also be reassuring, suggests a team of scientific and policy experts at Vanderbilt University. According toRead more
More
Nov 27,2018
35 Genes Shape Risk to Chronic Kidney Disease
Understanding the genetic makeup of complex chronic diseases is a significant step toward developing advanced diagnostics and better treatment options. In that vein, an international team of investigators led by scientists at the University of Manchester put together an extensive genome-wide association study (GWAS) to identify the genetic factors that predispose people to chronic kidneyRead more
More
Nov 26,2018
Cancer Cells Stopped from Metastasizing along Highways in Tumors
Researchers at the University of Minnesota have developed a technique to stop cancer cells from moving and metastasizing. The discovery could have a major impact on millions of people undergoing therapies to prevent the spread of cancer within the body, according to the scientists.   It's been known for years that tumors have patterns thatRead more
More
Nov 26,2018
African Sleeping Sickness Lifecycle Secrets Revealed
The tiny Teste fly has been a scourge for centuries in many parts of Africa, spreading the debilitating and even deadly disease called African sleeping sickness. Now, investigators from Clemson University have released new findings focusing on the biological cues that signal the parasite which causes the disease – Trypanosoma brucei – to change lifeRead more
More
African Sleeping Sickness Lifecycle Secrets Revealed
Nov 21,2018
Lung Cancer Treatment Approach May Support Disease Progression
Epigenetic regulators that modify factors involved in switching genes on and off represent attractive anticancer targets, but whether this strategy will work in vivo hasn't yet been proven. Studies in mice by researchers headed by a Boston Children's Hospital team now suggest that blocking one epigenetic regulator – a histone methyltransferase known as G9a –Read more
More
Lung Cancer Treatment Approach May Support Disease Progression
Stock Code
688202

Global

Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)

Tel: +1(626)986-9880(U.S.)

Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK

Tel: 0044 7790 816 954 (Europe)

Email: marketing@medicilon.com

  

Address: 5th Floor, 62, Banpodae-ro 4-gil, Seocho-gu, Seoul, 06719 South Korea

Tel: +82 70-8269-5849

China

Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)

Postcode: 201299

Tel: +86 (21) 5859-1500 (main line)

Fax: +86 (21) 5859-6369

Facebook icon
Twitter icon
Linkedin icon
Youtube icon
© 2023 Shanghai Medicilon Inc. All rights reserved All Rights Reserved Privacy Policy
Website Map
-->